T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
about
Antihelminthics in helminth-endemic areas: effects on HIV disease progressionTreatment of helminth co-infection in HIV-1 infected individuals in resource-limited settingsReduced CD4 T cell activation and in vitro susceptibility to HIV-1 infection in exposed uninfected Central AfricansIncreased sensitivity of CD4+ T-effector cells to CD4+CD25+ Treg suppression compensates for reduced Treg number in asymptomatic HIV-1 infectionTreatment of helminth co-infection in individuals with HIV-1: A systematic review of the literature.Systematic identification of synergistic drug pairs targeting HIVInfection with different hiv subtypes is associated with CD4 activation-associated dysfunction and apoptosis.Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan AfricaThe Distribution and Immune Profile of T Cell Subsets in HIV-Infected Children from UgandaPlasmodium falciparum dihydrofolate reductase and dihyropteroate synthase mutations and the use of trimethoprim-sulfamethoxazole prophylaxis among persons infected with human immunodeficiency virusPretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy.Innate and adaptive immune responses both contribute to pathological CD4 T cell activation in HIV-1 infected Ugandans.HIV-induced T-cell activation/exhaustion in rectal mucosa is controlled only partially by antiretroviral treatmentHIV+ elite controllers have low HIV-specific T-cell activation yet maintain strong, polyfunctional T-cell responses.Th-1-type cytotoxic CD8+ T-lymphocyte responses to simian immunodeficiency virus (SIV) are a consistent feature of natural SIV infection in sooty mangabeys.Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children.Immunologic basis for revaccination of HIV-infected children receiving HAART.Characteristics of CD8+ T cell subsets in Chinese patients with chronic HIV infection during initial ART.Immune exhaustion occurs concomitantly with immune activation and decrease in regulatory T cells in viremic chronically HIV-1-infected patientsActivation of CD8 T cells predicts progression of HIV infection in women coinfected with hepatitis C virusImpact of elevated maternal HIV viral load at delivery on T-cell populations in HIV exposed uninfected infants in MozambiqueSex differences in HIV RNA level and CD4 cell percentage during childhoodAlterations in T cell subsets in human immunodeficiency virus-infected adults with co-infections in southern Mozambique.HIV Type 1 Disease Progression to AIDS and Death in a Rural Ugandan Cohort Is Primarily Dependent on Viral Load Despite Variable Subtype and T-Cell Immune Activation LevelsPredictors of disease progression in HIV infection: a review.Assessment of the impact of adherence and other predictors during HAART on various CD4 cell responses in resource-limited settings.Immune Activation at Sites of HIV/TB Co-Infection Contributes to the Pathogenesis of HIV-1 Disease.Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy.CD4 T-cell activation and reduced regulatory T-cell populations are associated with early development of cataracts among HIV-infected adults in Uganda.Sub-optimal CD4 reconstitution despite viral suppression in an urban cohort on antiretroviral therapy (ART) in sub-Saharan Africa: frequency and clinical significancePolychromatic immunophenotypic characterization of T cell profiles among HIV-infected patients experiencing immune reconstitution inflammatory syndrome (IRIS).Mendelian randomization: potential use of genetics to enable causal inferences regarding HIV-associated biomarkers and outcomes.Comparison of viro-immunological marker changes between HIV-1 and HIV-2-infected patients in France.Distinct cytokine patterns in semen influence local HIV shedding and HIV target cell activation.Unrecognised tuberculosis at antiretroviral therapy initiation is associated with lower CD4+ T cell recovery.Profile of T cell immune responses in HIV-infected children from Uganda.HIV Subtypes Distribution and Implication for Antiretroviral Treatment in a Ugandan Population.Effect of Antiretroviral Therapy on the Memory and Activation Profiles of B Cells in HIV-Infected African WomenImmune Activation and HIV-Specific CD8(+) T Cells in Cerebrospinal Fluid of HIV Controllers and Noncontrollers.T cell anergy and activation are associated with suboptimal humoral responses to measles revaccination in HIV-infected children on anti-retroviral therapy in Nairobi, Kenya.
P2860
Q24185903-EE11215B-6EB0-4225-92CD-28C8C3C9A7C6Q24242130-8B0F074A-045F-4F4B-AC72-2C2C22A24F8EQ27473420-B3ABA3B4-E853-4B7E-960B-F5C0208F4E41Q28748867-7EB7365D-9217-4EF7-B639-3D5A1BBCB2CBQ30366829-1D453098-68F5-464E-89CB-1C5456069174Q30422333-1C35DA57-C8C3-404D-BC26-08801E8AAD9DQ33552482-8DA9025F-10A9-4230-85E7-33EEC99F07BBQ33580153-438AD1E5-FEDD-4C48-BF98-A42905A1D263Q33805240-D8219D5E-B1C2-440C-B09C-78AC93ED60C0Q33817605-7198DDDD-49CB-40A9-B020-90F67B345EE1Q33862741-97812D3A-72E3-4B06-A6EE-82B3C88854E2Q33883704-FE7473C4-C41E-43A3-B000-262B6FAB71A8Q34140484-37AA7354-038B-4555-86B9-3AD46BAC99F6Q34275430-96D5E75D-2D16-4B37-9353-D8A4279A42F2Q34434974-33096D6A-B73D-44C7-93F9-F93DA1E5C944Q34547637-DABDC389-9199-48EB-97ED-61600E067B40Q34575987-D27F0328-3E47-474D-989C-B50CABA70969Q34778365-FB152305-2B97-4D67-8849-D93E8E72DA41Q34984010-CAB4E6FB-0A84-481F-84EF-6B573AD7BB50Q35018396-36F5B42F-1DDA-404D-A19A-3ACC8651911AQ35059981-7B53EAC4-272B-4C2D-9EEC-2D9BF4FF216FQ35178669-B241C7B7-DD71-46B0-9C62-C5261B0211EAQ35246201-D2AF03C2-CA9F-4F34-85E1-3E8B882640C5Q35588137-D4A0C60A-5E6B-46AA-B611-8D071CBBDAD9Q35834337-8D874F41-6591-4A01-A2CD-C390D7C50DEFQ35905907-35D568E5-54E5-425F-87E7-97F0D8B4484EQ36199763-085594C9-57C8-43A7-B605-867659002BF7Q36344908-AFC4ACFC-AFD4-4433-907C-41FBBA4B5045Q37002936-AA4E9F08-11F2-451A-BE32-6BBC97B4D7CDQ37021073-B6E9A567-8C3D-4E71-936A-D6AACD532468Q37295455-EFFF95AC-D8C5-428B-AC1E-D97190DB049BQ37295610-ACCA4607-CC43-47D5-A638-0B73190B26BCQ37307096-32D2888D-11B3-4747-9CD9-109B3B8092E5Q37671942-8F90D2A8-5373-41E7-B019-A0398C6C1897Q38866845-E5E73A6C-1BB6-4B25-BE03-9BB4E92A30B6Q38877200-522E2E54-F1BB-4392-8601-C0533AF0F39BQ38877717-033D90A3-BD08-466A-AA66-9CBE46F937E6Q39048750-A8D87484-7388-456D-BB91-E142E96E6E4BQ40739042-E99B555D-38F2-4F51-B1CC-407EC0D1EC68Q41295794-7E93A825-9DBB-4517-BD7D-4FCDF80EEC9E
P2860
T cell activation in HIV-seropositive Ugandans: differential associations with viral load, CD4+ T cell depletion, and coinfection.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
T cell activation in HIV-serop ...... ll depletion, and coinfection.
@en
type
label
T cell activation in HIV-serop ...... ll depletion, and coinfection.
@en
prefLabel
T cell activation in HIV-serop ...... ll depletion, and coinfection.
@en
P2093
P356
P1476
T cell activation in HIV-serop ...... ll depletion, and coinfection.
@en
P2093
Banson Barugahare
Cissy Kityo
Mark P Eggena
Martin Okello
Norman Jones
Peter Mugyenyi
Steven Mutyala
P304
P356
10.1086/427516
P407
P577
2005-01-31T00:00:00Z